IL-27 induction of IL-21 from human CD8 T cells induces granzyme B in an autocrine manner

Immunology and Cell Biology

Volumn 90, Issue 8, 2012, Pages 831-835

  Mittal, Akanksha ^a   Murugaiyan, Gopal ^a   Beynon, Vanessa ^a   Hu, Dan ^a   Weiner, Howard L ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Granzyme B; human CD8P T; IL 27 and IL 21

Indexed keywords

GAMMA INTERFERON; GRANZYME A; GRANZYME B; INTERLEUKIN 21; INTERLEUKIN 27; TRANSCRIPTION FACTOR T BET;

ARTICLE; AUTOCRINE EFFECT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANIMALS; AUTOCRINE COMMUNICATION; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; ENZYME INDUCTION; GRANZYMES; HUMANS; INTERFERON-GAMMA; INTERLEUKINS; LYMPHOCYTE ACTIVATION; MICE;

MUS;

EID: 84866366930     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2012.14     Document Type: Article

References (41)

1. Kastelein RA, Hunter CA, Cua DJ. Discovery and biology of IL-23 and IL-27: Related but functionally distinct regulators of inflammation. Annu Rev Immunol 2007; 25: 221-242.
2. Murugaiyan G, Mittal A, Weiner HL. Identification of an IL-27/osteopontin axis in dendritic cells and its modulation by IFN-gamma limits IL-17-mediated autoimmune inflammation. Proc Natl Acad Sci USA 2010; 107: 11495-11500.
3. Yoshida H, Miyazaki Y. Regulation of immune responses by interleukin-27. Immunol Rev 2008; 226: 234-247.
4. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW et al. Cutting edge: Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment. J Immunol 2003; 170: 4886-4890.
5. Yoshimoto T, Yasuda K, Mizuguchi J, Nakanishi K. IL-27 suppresses Th2 cell development and Th2 cytokines production from polarized Th2 cells: A novel therapeutic way for Th2-mediated allergic inflammation. J Immunol 2007; 179: 4415-4423.
6. Wang S, Miyazaki Y, Shinozaki Y, Yoshida H. Augmentation of antigen-presenting and Th1-promoting functions of dendritic cells by WSX-1(IL-27R) deficiency. J Immunol 2007; 179: 6421-6428.
7. Fitzgerald DC, Ciric B, Touil T, Harle H, Grammatikopolou J, Das Sarma J et al. Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J Immunol 2007; 179: 3268-3275.
8. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, Lucas S et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006; 7: 929-936.
9. Pot C, Apetoh L, Awasthi A, Kuchroo VK. Molecular pathways in the induction of interleukin-27-driven regulatory type 1 cells. J Interferon Cytokine Res 2010; 30: 381-388.
10. Stumhofer JS, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008; 117: 123-130.
11. Morishima N, Owaki T, Asakawa M, Kamiya S, Mizuguchi J, Yoshimoto T. Augmentation of effector CD8 T cell generation with enhanced granzyme B expression by IL-27 J Immunol 2005; 175: 1686-1693.
12. Chiyo M, Shimozato O, Yu L, Kawamura K, Iizasa T, Fujisawa T et al. Expression of IL-27 in murine carcinoma cells produces antitumor effects and induces protective immunity in inoculated host animals. Int J Cancer 2005; 115: 437-442.
13. Salcedo R, Stauffer JK, Lincoln E, Back TC, Hixon JA, Hahn C et al. IL-27 mediates complete regression of orthotopic primary and metastatic murine neuroblastoma tumors: Role for CD8 T cells. J Immunol 2004; 173: 7170-7182.
14. Spolski R, Leonard WJ. Interleukin-21: Basic biology and implications for cancer and autoimmunity. Annu Rev Immunol 2008; 26: 57-79.
15. Coquet JM, Kyparissoudis K, Pellicci DG, Besra G, Berzins SP, Smyth MJ et al. IL-21 is produced by NKT cells and modulates NKT cell activation and cytokine production. J Immunol 2007; 178: 2827-2834.
16. Spolski R, Leonard WJ. IL-21 and T follicular helper cells. Int Immunol 2010; 22 7-12.
17. Monteleone G, Pallone F, Macdonald TT. Interleukin-21 (IL-21)-mediated pathways in T cell-mediated disease. Cytokine Growth Factor Rev 2009; 20: 185-191.
18. Pot C, Jin H, Awasthi A, Liu SM, Lai CY, Madan R et al. Cutting edge: IL-27 induces the transcription factor c-Maf, cytokine IL-21, and the costimulatory receptor ICOS that coordinately act together to promote differentiation of IL-10-producing Tr1 cells. J Immunol 2009; 183: 797-801.
19. Spolski R, Kim HP, Zhu W, Levy DE, Leonard WJ. IL-21 mediates suppressive effects via its induction of IL-10. J Immunol 2009; 182: 2859-2867.
20. Zeng R, Spolski R, Finkelstein SE, Oh S, Kovanen PE, Hinrichs CS et al. Synergy of IL-21 and IL-15 in regulating CD8 T cell expansion and function. J Exp Med 2005; 201: 139-148.
21. Batten M, Ramamoorthi N, Kljavin NM, Ma CS, Cox JH, Dengler HS et al. IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells. J Exp Med 2010; 208: 115-123.
22. Linterman MA, Beaton L, Yu D, Ramiscal RR, Srivastava M, Hogan JJ et al. IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responses. J Exp Med 2010; 207: 353-363.
23. Zotos D, Coquet JM, Zhang Y, Light A, D'Costa K, Kallies A et al. IL-21 regulates germinal center B cell differentiation and proliferation through a B cell-intrinsic mechanism. J Exp Med 2010; 207: 365-378.
24. Williams LD, Bansal A, Sabbaj S, Heath SL, Song W, Tang J et al. Interleukin-21-producing HIV-1-specific CD8 T cells are preferentially seen in elite controllers. J Virol 2011; 85: 2316-2324.
25. Chtanova T, Tangye SG, Newton R, Frank N, Hodge MR, Rolph MS et al. T follicular helper cells express a distinctive transcriptional profile, reflecting their role as non-Th1/Th2 effector cells that provide help for B cells. J Immunol 2004; 173: 68-78.
26. Wurster AL, Rodgers VL, Satoskar AR, Whitters MJ, Young DA, Collins M et al. Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J Exp Med 2002; 196: 969-977.
27. Korn T, Bettelli E, Gao W, Awasthi A, Jager A, Strom TB et al. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 2007; 448: 484-487.
28. Nurieva R, Yang XO, Martinez G, Zhang Y, Panopoulos AD, Ma L et al. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007; 448: 480-483.
29. Zhou L, Ivanov II, Spolski R, Min R, Shenderov K, Egawa T et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-974.
30. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, Chavez R, Lascurain R. Cell death mechanisms induced by cytotoxic lymphocytes. Cell Mol Immunol 2009; 6: 15-25.
31. Skak K, Sondergaard H, Frederiksen KS, Ehrnrooth E. In vivo antitumor efficacy of interleukin-21 in combination with chemotherapeutics. Cytokine 2009; 48: 231-238.
32. Sondergaard H, Galsgaard ED, Bartholomaeussen M, Straten PT, Odum N, Skak K. Intratumoral interleukin-21 increases antitumor immunity, tumor-infiltrating CD8 T-cell density and activity, and enlarges draining lymph nodes. J Immunother 2010; 33: 236-249.
33. Hagn M, Schwesinger E, Ebel V, Sontheimer K, Maier J, Beyer T et al. Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. J Immunol 2009; 183: 1838-1845.
34. Schneider R, Yaneva T, Beauseigle D, El-Khoury L, Arbour N. IL-27 increases the proliferation and effector functions of human naive CD8 T lymphocytes and promotes their development into Tc1 cells. Eur J Immunol 2011; 41: 47-59.
35. Murugaiyan G, Mittal A, Lopez-Diego R, Maier LM, Anderson DE, Weiner HL. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4 T cells. J Immunol 2009; 183: 2435-2443.
36. Hisada M, Kamiya S, Fujita K, Belladonna ML, Aoki T, Koyanagi Y et al. Potent antitumor activity of interleukin-27. Cancer Res. 2004; 64: 1152-1156.
37. Salcedo R, Hixon JA, Stauffer JK, Jalah R, Brooks AD, Khan T et al. Immunologic and therapeutic synergy of IL-27 and IL-2: Enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow. J Immunol 2009; 182: 4328-4338.
38. Shimizu M, Shimamura M, Owaki T, Asakawa M, Fujita K, Kudo M et al. Antiangiogenic and antitumor activities of IL-27. J Immunol 2006; 176: 7317-7324.
39. Spolski R, Leonard WJ. The Yin and Yang of interleukin-21 in allergy, autoimmunity and cancer. Curr Opin Immunol 2008; 20: 295-301.
40. Davis ID, Brady B, Kefford RF, Millward M, Cebon J, Skrumsager BK et al. Clinical and biological efficacy of recombinant human interleukin-21 in patients with stage IV malignant melanoma without prior treatment: A phase IIa trial. Clin Cancer Res 2009; 15: 2123-2129.
41. Murugaiyan G, Mittal A, Weiner HL. Increased osteopontin expression in dendritic cells amplifies IL-17 production by CD4 T cells in experimental autoimmune encephalomyelitis and in multiple sclerosis. J Immunol 2008; 181: 7480-7488.